G01N 2333/5412
Il-6
G01N2333/5412 (Il-6) appears on 164 US grants and 432 published applications in this corpus.
Search patents in G01N- Granted patents
- 164
- Published applications
- 432
- Assignees
- 275
- Inventors
- 896
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 7 |
| 2004 | 0 | 0 |
| 2005 | 2 | 4 |
| 2006 | 2 | 3 |
| 2007 | 1 | 8 |
| 2008 | 2 | 9 |
| 2009 | 0 | 13 |
| 2010 | 6 | 14 |
| 2011 | 8 | 14 |
| 2012 | 5 | 11 |
| 2013 | 3 | 7 |
| 2014 | 5 | 14 |
| 2015 | 6 | 27 |
| 2016 | 4 | 34 |
| 2017 | 9 | 20 |
| 2018 | 12 | 22 |
| 2019 | 12 | 26 |
| 2020 | 15 | 28 |
| 2021 | 8 | 27 |
| 2022 | 12 | 25 |
| 2023 | 11 | 27 |
| 2024 | 13 | 26 |
| 2025 | 13 | 35 |
| 2026 | 11 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Equine multiplex health information panel22 Sep 2026US 12,742,788 B1Boundless Diagnostics Inc
- Controlled release of antibodies to modulate cytokines8 Sep 2026US 12,729,237 B2Flow Pharma, Inc.
- Methods of treating an autoimmune disease with a human interleukin-3 (IL-3)-diphtheria toxin conjugate (DT-IL3)14 Jul 2026US 12,678,485 B2Stemline Therapeautics, Inc.
- Cytokine-based therapies and methods30 Jun 2026US 12,668,627 B2Reverb Therapeutics, Inc.
- Methods, assays and systems for detection of a target analyte21 Apr 2026US 12,607,589 B2Sorrento Therapeutics, Inc.
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Multi-Analyte Rapid Diagnostic Test for Sepsis Using Novel Biomarkers and Quantum Dot Technology1 Oct 2026US 2026/0298921 A1Trimar Domestic Inc.
- Methods of treating alzheimer's disease17 Sep 2026US 2026/0274931 A1Klaritos, Inc.
- Novel cytokine-based therapies and methods17 Sep 2026US 2026/0274943 A1Reverb Therapeutics, Inc.
- Biomarkers for predicting cancer treatment efficacy10 Sep 2026US 2026/0266828 A1Arcus Biosciences, Inc.
Most cited
By later US patents
- Methods and apparatus for conducting multiple measurements on a sample125US 7,858,321 B2Meso Scale Technologies, LLC. · 2010
- Specific binding agents for KSHV vIL-6 that neutralize a biological activity62US 7,108,981 B2The United States of America as represented by the Department of Health and Human Services · 2006
- Specific binding agents for KSHV vIL-6 that neutralize a biological activity55US 6,939,547 B2The United States of America as represented by the Department of Health and Human Services · 2005
- Specific binding agents for KSHV vIL-6 that neutralize a biological activity55US 7,235,365 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services · 2007
- Specific binding agents for KSHV vIL-6 that neutralize a biological activity55US 7,374,756 B2The United States of America as represented by the Department of Health and Human Services · 2008